Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders for Apollo Commercial Real Estate Finance, Inc. held on June 10, 2025. The filing details the voting outcomes for director elections, auditor ratification, and executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 106,619,312 shares were represented at the meeting, constituting approximately 76.7% of the issued and outstanding shares entitled to vote. The following proposals were approved:
- Director Elections: All nine nominees were elected for a term expiring in 2026. Votes withheld ranged from approximately 948,000 to 11.3 million depending on the candidate.
- Auditor Ratification: Stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. The vote was 103,497,421 for, 2,897,992 against, and 223,899 abstentions.
- Executive Compensation: Stockholders approved, on an advisory basis, the compensation of named executive officers. The vote was 76,102,816 for, 4,165,099 against, and 514,073 abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. Detailed descriptions of the proposals are referenced as being available in the Company's 2025 Proxy Statement.
Investor Verification Checklist
- Verify the full list of elected directors and their biographies in the 2025 Proxy Statement.
- Review the specific compensation details for named executive officers referenced in the advisory vote.
- Confirm the scope of services and fees for Deloitte & Touche LLP as detailed in the Proxy Statement.
- Check for any dissenting opinions or significant broker non-votes that may indicate shareholder sentiment issues.